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INDUCTION OF ALLERGIC CONTACT DERMATITIS IN PATIENTS WITH THE
LYMPHOMA-LEUKEMIA COMPLEX*
WILLIAM L. EPSTEIN, M.D.t
There is considerable evidence that delayed
hypersensitivity reactions to bacterial, viral and
fungal antigens are diminished in patients with
the lymphoma-leukemia complex, viz: Hodgkin's
Disease, lymphosarcoma, leukemia, multiple
myeloma, etc. (see Reviewl)2 3 4 5 6 •
The present study concerns the experimental
induction in these patients of allergic contact
dermatitis, a form of delayed hypersensitivity.
MATERIALs AND METHODS
Two potent sensitizers were used (1) 2,4-
dinitrochlorobenzene (DNCB) and (2) paranitro-
sodimethyl aniline (NDMA). To sensitize 0.25
ml of 0.005 molar DNCB and 0.005 molar
NDMA dissolved in acetone were applied to the
skin at separate sites within the area of a cup 2.9
cm in diameter. The acetone was evaporated
under a stream of air, and the site covered with a
band-aid. To determine whether sensitization
had occurred, the subjects were retested 30 days
later by a similar application at new sites with a
1:1000 dilution of each sensitizer in acetone; the
reactions were observed in 4 to 6 days. They were
graded from 1 plus (erythema and edema) to 4
plus (bulla).
The subjects were 27 patients with the lym-
phoma-leukemia complex; the pertinent data is
as follows:
1. All were ambulatory out-patients who were
not acutely ill at the time of testing.
2. There were 5 with Hodgkin's disease, 9 with
some other form of lymphosarcoma, 5 with myc-
logenous leukemia, 3 with lymphocytic leukemia,
3 with multiple myeloma and 1 with extensive
mycosis fungoides. These have been grouped
together because of the small numbers in each
class.
3. 17 were white and 10 were Negro.
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4. There were 6 women and 21 men whose ages
ranged from 19 to 75 years.
5. 15 patients were not on therapy and had
received none for at least one month prior to sen-
sitization. The others received various doses and
combinations of local x-rays, radiomimetic drugs
and corticosteroids.
6. Only 4 subjects had total white blood counts
below 4000 per cu. mm.
In regards to the 262 control subjects:
1. All were healthy.
2. 114 were Negro males and 79 were white
women.
3. 35 were over 60 years old, while the others
varied between 20 and 60.
Because previous studies have indicated that
a racial difference exists in the response to con-
tact allergens,8 the Negro and white groups
were evaluated separately.
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RESULTS
The results are summarized in tables I and II.
Sensitization to both DNCB and NDMA was
markedly reduced in the lymphoma-leukemia
group. The distribution of positive reactors was
about the same in each subclass although the
numbers are too small for analysis. Of all the
patients only 2 white subjects (2/17 = 12%)
reacted to both allergens, whereas, the expected
frequency among healthy subjects is 64% for
white and about 35% for Negroes. Furthermore,
the intensity of sensitization as indicated by the
degree of inflammation was depressed. Not one
patient had a patch test reaction greater than 2
plus, while the majority showed very weak,
borderline reactions. On the contrary the reac-
tions were decidedly stronger in the control
subjects:
3 to 4 plus rçactors
DNCB NDMA
Negro 19/114 = 17% 24/105 = 22%
White 33/129 = 26% 37/129 = 29%
It should be noted also that only one of the
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TABLE I
White subjects
DNCB NDMA
Controls 125/148 = 83% 104/148 = 70%
Patients with 5/16 = 31% 1/16 = 6%
lymphoma-
leukemia com-
plext
F Valuet <.001 <.001
* The patient with mycosis fungoides was
dropped because he had to be hospitalized before
the completion of the study. His patch test re-
actions were negative.
t 0.05 was taken as the level of significance.
TABLE II
Negro subjects
DNCB NDMA
Controls 70/114 = 61% 49/108 = 45%
Patients with 1/10 = 10% 3/10 = 30%
lymphoma-
leukemia
complex
P Value <.01 Not significant
positive reactors was receiving any therapy; the
other 7 were well enough not to be on any
treatment.
COMMENT
The diminished susceptibility to contact sensi-
tization corresponds to the lowered reactivity
demonstrated by these patients to other delayed
type antigens. It was only in the case of the
NDMA-treated Negroes that the frequency of
sensitization, while definitely lower, was not so
depressed as to have statistical significance.
In a somewhat similar study Rostenberg et al'°
arrived at essentially the same conclusion; how-
ever, since their hospitalized patients and controls
were acutely ill the uncertainty remained that
the results were due to cachexia and not to the
particular effect of the disease complex. In our
study the patients were ambulatory and not
especially ill.
The significance of this diminished capacity
for delayed reactivity is not understood. The
most popular explanation is that the cells respon-
sible for producing delayed "antibodies" are
crowded out by the neoplastie-non-antibody
forming reticulum cells.2 ' However, this con-
cept must remain a speculation so long as the
site of synthesis of delayed "antibodies" is
unknown.
SUMMARY
(1) The frequency of sensitization to two
contact allergens, 2, 4-dinitrochlorobenzene and
paranitrosodimethyl aniline, was determined in
27 patients with the lymphoma-leukemia com-
plex.
(2) These patients have a markedly decreased
capacity to react to contact sensitizers. This
corresponds to their decreased sensitivity to
other delayed type allergens.
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